Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Polatuzumab-R-CHP

This drug is selected. Its supporting articles are shown below.

1 articles · page 1 of 1

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

85.3%

… eligible-ASCT)YesGO29365:Multicentre/open-label/phase Ib/II vs.Rituximab/bendamustine2A (OS improvement)Improved mPFS by 5.8 mo(HR=0.36)…